Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1509-1512

  Fukushi, Shuetsu ^a   Mizutani, Tetsuya ^a   Saijo, Masayuki ^a   Kurane, Ichiro ^a   Taguchi, Fumihiro ^a   Tashiro, Masato ^a   Morikawa, Shigeru ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Neutralization; Pseudotype; SARS coronavirus; VSV

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; HEALTH CARE PERSONNEL; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NONHUMAN; SARS CORONAVIRUS; SERODIAGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; VESICULAR STOMATITIS VIRUS; VIET NAM; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS TYPING;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; HUMANS; MEMBRANE GLYCOPROTEINS; NEUTRALIZATION TESTS; RECOMBINATION, GENETIC; SARS VIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

SARS CORONAVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33750569563     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20732     Document Type: Article

References (11)

1. Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S. 2005. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86:2269-2274.
2. Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH, Gramberg T, Pohlmann S. 2004. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun 319:1216-1221.
3. Hong TC, Mai QL, Cuong DV, Parida M, Minekawa H, Notomi T, Hasebe F, Morita K. 2004. Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 42:1956-1961.
4. Hourfar MK, Roth WK, Seifried E, Schmidt M. 2004. Comparison of two real-time quantitative assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 42:2094-2100.
5. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
6. Nie Y, Wang P, Shi X, Wang G, Chen J, Zheng A, Wang W, Wang Z, Qu X, Luo M, Tan L, Song X, Yin X, Ding M, Deng H. 2004. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. Biochem Biophys Res Commun 321:994-1000.
7. Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J. 2003. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 10:154-160.
8. Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. 2005. Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods 125:181-186.
9. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 94:14764-14769.
10. Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA. 2005. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 11:411-416.
11. WHO. 2003. Summary of probable cases with onset of illness from 1 November 2002 to 31 July 2003. World Health Organization.